Leadership

Mark L. Baum, J.D.

Chief Executive Officer, Member, Board of Directors

Mr. Baum is a founder, member of the board of directors and Chief Executive Officer of the company. Read More
Andrew R. Boll, CFA, CMA

Chief Financial Officer

Mr. Boll joined Imprimis in December 2011 as a consultant until he was hired as Vice President of Accounting and Public Reporting (Principal Financial and Accounting Officer) of the company in February 2012. Read More
John Saharek

Chief Commercial Officer

Mr. Saharek started with Imprimis as Vice President of Commercialization, Ophthalmology in November 2013 until his promotion to Chief Commercial Officer in February 2015. Read More
Clayton D. Edwards

Chief Operating Officer

Mr. Edwards is Chief Operating Officer of Imprimis where he oversees the company’s operations, including pharmacy, production, dispensing, customer service, Information Technology and quality. Read More
Eric Rice

Vice President, Client Relations

Mr. Rice has been the Vice President of Client Relations at Imprimis since July 2016 and is responsible for implementing new processes to improve efficiencies with the ultimate goal of building Imprimis’ customer service department into a center of excellence. Read More
Pramod Sharma

Vice President, Quality

Mr. Sharma has been the Vice President of Quality since August 2016 and oversees the expansion of all Imprimis quality systems in line with the highest pharmaceutical and compounding industry standards. Read More
Sanjay Samudre

Vice President, Manufacturing

Mr. Samudre has been the Vice President of Manufacturing at Imprimis since May 2016 where he oversees supply chain and production while adding automation and scalability to many the company’s core compounded formulations. Read More
David Moufarrege

Vice President, Technology

Mr. Moufarrege oversees all company technology operations, including technical infrastructure, software development, and integrations. Read More
Victor Repkin

Intellectual Property Counsel

Dr. Repkin has served as patent attorney and intellectual property counsel for Imprimis since June 2013. Read More
Bonnie Ortega

Director of Investor Relations & Corporate Communications

Ms. Ortega has 20 years of experience building and managing investor and media relations programs for publicly-traded biotechnology, pharmaceutical and medical device companies. Read More